Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

The Impact of Domiciliary Versus 'Hub' Based Comprehensive Geriatric Assessment on Clinical and Process Outcomes Among Older Adults Attending Community Specialist Teams: a Randomised Controlled Trial.

NCT06205238 · tracked via the Priya Life Science Ireland tracker
Phase
Not applicable
Started
2024-01-15
Last updated
2025-08-20

Condition(s) studied

FrailtyComprehensive Geriatric AssessmentOlder AdultsDomiciliary Care

Investigational drug(s) / intervention(s)

CGA

CGA: CGA is defined as a "multidimensional interdisciplinary diagnostic process focused on determining a frail elderly person's medical, psychological and functional capability in order to develop a coordinated and integrated plan for treatment and long term follow up".

Study summary

The investigators plan to implement a randomised controlled trial to examine the impact of domiciliary (home based) versus 'hub-based' Comprehensive Geriatric Assessment (CGA) on clinical and process outcomes among older adults referred to a community specialist team for older persons in the Mid-West region of Ireland. The population of interest is older adults who are discharged directly from the Emergency Department or referred urgently from their General Practitioner. The outcomes of interest focus on those that matter most to older adults as well as clinical and process measures of care.

Eligibility

Sex
ALL
Min age
75 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Referred to the CST hub from a General Practitioner (urgent referral) or from the ED at University Hospital Limerick. All of criteria 1-5 must be met 1. 75 years and over 2. Evidence of frailty, scoring between 4 and 6 on the Rockwood Clinical Frailty Scale (pre-frail, mildly frail or moderately frail) 3. Resides within CHO 3 and the catchment area of the relevant ICPOP hub 4. Patient has been assessed in-person by the referrer 5. Patient has not had MDT input within the last three months (excluding OPTIMEND team) And any one of criteria 6-10 must be met: 6. Fall within the last month unrelated to acute cardiac or neurological cause \& no previous falls assessment 7. Increased dependency or increased carer burden in the last month 8. A deterioration in swallow in the last month including symptoms of recurrent chest infections, weight loss, coughing when eating/drinking, self-modifying diet secondary to difficulties 9. Adverse drug reaction within the last month excluding allergic reaction Referred from ED/AMU following review by consultant in Emergency Medicine, Acute Medicine, Geriatric Medicine, General Medicine or Frailty at the Front Door team Exclusion Criteria: * Present with an acute neurological or cardiovascular event * Are more appropriate to an alternative care pathway or service e.g. primary care or geriatric medicine clinic * Present with injuries, unless the injury has already been appropriately managed, * Are experiencing an acute medical illness requiring treatment in an acute hospital setting * If care is being provided by other health care professionals at the time of referral and it is apparent that they are working to meet goals aligned with the current service * They require investigation or treatment not available in the relevant ICPOP hub (unless these investigations are already being arranged elsewhere) * They have had MDT input in the last three months * Have confirmed or suspected Covid-19 infection * Or other exclusions at the discretion of the integrated care team based on clinical expertise and available resource.

Primary outcome measure(s)

  • Functional status — Baseline
    Barthel Index
  • Functional status — 6-weeks
    Barthel Index
  • Functional status — 6-months
    Barthel Index
  • Functional status — 12-months
    Barthel Index

Trial sites (1)

FacilityCityRegionStatus
Community Specialist Team Hub Limerick Munster
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06205238 on ClinicalTrials.gov ↗ ← All trials in Ireland